3C
MGNX icon

361 Capital’s MacroGenics MGNX Stock Holding History

361 Capital’s Portfolio MGNX Stock Details MGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-178,479
Closed -$2.28M – 374
2019
Q3 		$2.28M Buy
+178,479
New +$2.57M 0.42% 130
2019
Q2 		– Sell
-114,585
Closed -$2.06M – 358
2019
Q1 		$2.06M Sell
114,585
-40,132
-26% -$694K 0.36% 153
2018
Q4 		$1.97M Buy
+154,717
New +$2.59M 0.4% 138

Other funds holding MGNX

BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

361 Capital's MGNX Position: Q4 2019 in Review

361 Capital sold out of MacroGenics (MGNX) in Q4 2019, closing a stake of 178,479 shares — an estimated $2.28M sold.

361 Capital first reported a position in MGNX in Q4 2018 and held it in 3 quarters. The position peaked at $2.28M in Q3 2019. 124 funds tracked by Wall St. Rank hold MGNX as of Q4 2019.

  • 361 Capital reported no remaining MacroGenics position as of Q4 2019 after selling out during the quarter.
  • 361 Capital sold 178,479 MacroGenics shares in Q4 2019, an estimated $2.28M.
  • 361 Capital first reported a position in MacroGenics in Q4 2018 and held it in 3 quarters.
  • 361 Capital's MacroGenics position peaked at $2.28M in Q3 2019.
  • 124 funds tracked by Wall St. Rank held MacroGenics as of Q4 2019.

Based on 361 Capital's 13F filing for Q4 2019, filed 13 Feb 2020.